STANLEY T CROOKE Insider Trading for January 2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for STANLEY T CROOKE.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Overview of insider trading of STANLEY T CROOKE for January 2017.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 18 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 0.00 | 334 | 0 | 999 | |
Jan 18 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 0.00 | 363 | 0 | 724 | |
Jan 18 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 0.00 | 354 | 0 | 354 | |
Jan 18 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 0.00 | 416 | 0 | 0 | |
Jan 18 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 0.00 | 8,133 | 0 | 24,397 | |
Jan 18 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 0.00 | 6,875 | 0 | 13,750 | |
Jan 18 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 0.00 | 7,812 | 0 | 7,812 | |
Jan 18 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 0.00 | 5,547 | 0 | 0 | |
Jan 18 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | A | 0.00 | 2,692 | 0 | 2,692 | |
Jan 18 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | A | 0.00 | 27,168 | 0 | 27,168 | |
Jan 18 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 46.29 | 131 | 6,064 | 3,062 | 3.2 K to 3.1 K (-4.10 %) |
Jan 18 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 0.00 | 334 | 0 | 3,193 | 2.9 K to 3.2 K (+11.68 %) |
Jan 18 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 46.29 | 142 | 6,573 | 2,859 | 3 K to 2.9 K (-4.73 %) |
Jan 18 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 0.00 | 363 | 0 | 3,001 | 2.6 K to 3 K (+13.76 %) |
Jan 18 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 46.29 | 139 | 6,434 | 2,638 | 2.8 K to 2.6 K (-5.01 %) |
Jan 18 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 0.00 | 354 | 0 | 2,777 | 2.4 K to 2.8 K (+14.61 %) |
Jan 18 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 46.29 | 163 | 7,545 | 2,423 | 2.6 K to 2.4 K (-6.30 %) |
Jan 18 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 0.00 | 416 | 0 | 2,586 | 2.2 K to 2.6 K (+19.17 %) |
Jan 18 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 46.29 | 4,410 | 204,139 | 38,014 | 42.4 K to 38 K (-10.40 %) |
Jan 18 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 0.00 | 8,133 | 0 | 42,424 | 34.3 K to 42.4 K (+23.72 %) |
Jan 18 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 46.29 | 3,728 | 172,569 | 34,291 | 38 K to 34.3 K (-9.81 %) |
Jan 18 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 0.00 | 6,875 | 0 | 38,019 | 31.1 K to 38 K (+22.07 %) |
Jan 18 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 46.29 | 4,236 | 196,080 | 31,144 | 35.4 K to 31.1 K (-11.97 %) |
Jan 18 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 0.00 | 7,812 | 0 | 35,380 | 27.6 K to 35.4 K (+28.34 %) |
Jan 18 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 46.29 | 3,008 | 139,237 | 27,568 | 30.6 K to 27.6 K (-9.84 %) |
Jan 18 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 0.00 | 5,547 | 0 | 30,576 | 25 K to 30.6 K (+22.16 %) |
Jan 12 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 10.29 | 1,200 | 12,348 | 2,600 | |
Jan 12 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 7.25 | 12,000 | 87,000 | 64,462 | |
Jan 12 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 49.25 | 1,200 | 59,100 | 2,170 | 3.4 K to 2.2 K (-35.61 %) |
Jan 12 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 10.29 | 1,200 | 12,348 | 3,370 | 2.2 K to 3.4 K (+55.30 %) |
Jan 12 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 49.25 | 12,000 | 591,000 | 25,029 | 37 K to 25 K (-32.41 %) |
Jan 12 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 7.25 | 12,000 | 87,000 | 37,029 | 25 K to 37 K (+47.94 %) |
Jan 04 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 10.29 | 700 | 7,203 | 3,800 | |
Jan 04 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 7.25 | 7,000 | 50,750 | 76,462 | |
Jan 04 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 10.29 | 1,000 | 10,290 | 4,500 | |
Jan 04 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 7.25 | 10,000 | 72,500 | 83,462 | |
Jan 04 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | A | 47.34 | 16,157 | 764,872 | 16,157 | |
Jan 04 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | A | 47.34 | 163,013 | 7,717,035 | 163,013 | |
Jan 04 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 50.10 | 700 | 35,070 | 2,170 | 2.9 K to 2.2 K (-24.39 %) |
Jan 04 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 10.29 | 700 | 7,203 | 2,870 | 2.2 K to 2.9 K (+32.26 %) |
Jan 04 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 50.10 | 7,000 | 350,700 | 25,029 | 32 K to 25 K (-21.86 %) |
Jan 04 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 7.25 | 7,000 | 50,750 | 32,029 | 25 K to 32 K (+27.97 %) |
Jan 04 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 48.80 | 500 | 24,400 | 2,170 | 2.7 K to 2.2 K (-18.73 %) |
Jan 04 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 10.29 | 500 | 5,145 | 2,670 | 2.2 K to 2.7 K (+23.04 %) |
Jan 04 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 47.30 | 500 | 23,650 | 2,170 | 2.7 K to 2.2 K (-18.73 %) |
Jan 04 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 10.29 | 500 | 5,145 | 2,670 | 2.2 K to 2.7 K (+23.04 %) |
Jan 04 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 48.80 | 5,000 | 244,000 | 25,029 | 30 K to 25 K (-16.65 %) |
Jan 04 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 7.25 | 5,000 | 36,250 | 30,029 | 25 K to 30 K (+19.98 %) |
Jan 04 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 47.30 | 5,000 | 236,500 | 25,029 | 30 K to 25 K (-16.65 %) |
Jan 04 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 7.25 | 5,000 | 36,250 | 30,029 | 25 K to 30 K (+19.98 %) |